TP53 and cancer: By elucidating the molecular mechanisms underpinning TP53 dysregulation and its intricate connections to key signaling pathways [43], we provide a foundation for the development of precision therapeutic interventions aimed at disrupting these pathways and improving clinical outcomes across diverse cancer types.